Otc - Active Ingredient
SALICYLIC ACID, TEA TREE OIL
Saliskin
FDA Label NDC 81376-500
Full FDA labeling including Indications, Dosage, Usage, and Precautions
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Ssg Ventures Inc for the product Saliskin (NDC 81376-500). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding package label.principal display panel, otc - active ingredient, inactive ingredient, dosage & administration, warnings, otc - purpose, otc - keep out of reach of children, indications & usage, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Inactive Ingredient
MEDIDERM CREAM, GREEN TEA EXTRACT, ALOE VERA, EMULTHIX
Dosage & Administration
WASH FACE THOROUGHLY AND APPLY TO AFFECTED AREAS. USE CONTINUOUSLY FOR AT LEAST 12 WEEKS FOR OPTIMAL RESULTS
Warnings
FOR EXTERNAL USE ONLY.
AVOID CONTACT TO EYES.
KEEP OUT OF REACH OF CHILDREN.
STOP USE AND CONSULT DOCTOR IF CONDITION WORSENS OR CLEARS UP AND REOOCCURS.
Otc - Purpose
REMOVES PIMPLES
MINIMIZES PORES
ENHANCED WITH TEA TREE OIL AND ALOE VERA
Otc - Keep Out Of Reach Of Children
KEEP OUT OF REACH FO CHILDREN
Indications & Usage
USE CONTINUOUSLY FOR AT LEAST 12 WEEKS FOR OPTIMAL RESULTS
* Please review the disclaimer below.
